Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Sarepta Therapeutics, Inc. (SRPT) had Return on Investments of -7.64% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$399.36M |
|
$-179.95M |
|
$150.78M |
|
$248.58M |
|
$502.75M |
|
$-103.39M |
|
$-90.66M |
|
$-194.05M |
|
$-194.05M |
|
$-179.95M |
|
$-179.95M |
|
$-179.95M |
|
$-179.95M |
|
$-103.39M |
|
$-86.07M |
|
100.24M |
|
100.24M |
|
$-1.80 |
|
$-1.80 |
|
| Balance Sheet Financials | |
$2.72B |
|
$358.94M |
|
$771.13M |
|
$3.49B |
|
$921.42M |
|
$1.04B |
|
$1.25B |
|
$2.17B |
|
$1.32B |
|
$1.32B |
|
$1.32B |
|
104.77M |
|
| Cash Flow Statement Financials | |
$-336.69M |
|
$-26.57M |
|
$-129.14M |
|
$1.12B |
|
$626.20M |
|
$-492.39M |
|
$93.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.95 |
|
-- |
|
-- |
|
0.44 |
|
0.78 |
|
62.25% |
|
-25.89% |
|
-25.89% |
|
-- |
|
-48.59% |
|
-45.06% |
|
$-435.07M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.14 |
|
1.01 |
|
89.18 |
|
-13.63% |
|
-13.63% |
|
-5.15% |
|
|
Return on Investments |
-7.64% |
$12.60 |
|
$-4.34 |
|
$-3.36 |
|